Pfizer has announced that it will be testing a third dose of its coronavirus vaccine to determine if it will offer better protection against variants of the virus.
“We believe that the third dose will raise the antibody response 10- to 20-fold," Pfizer CEO Albert Bourla said in an interview with NBC News.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.